Gender-Affirming Hormone Therapy in Primary Care Tied to Reduced Depressive Symptoms
By Lori Solomon HealthDay Reporter
MONDAY, March 24, 2025 -- Gender-affirming hormone therapy (GAHT) in primary care is associated with lower rates of moderate-to-severe depressive symptoms in U.S. transgender, nonbinary, and gender-diverse (TGD) adults over four years of follow-up, according to a study published online March 17 in JAMA Network Open.
Sari L. Reisner, Sc.D., from the University of Michigan in Ann Arbor, and colleagues evaluated the use of GAHT delivered in primary care as an intervention for moderate-to-severe depressive symptoms in diverse TGD adult patients. The analysis included 3,592 TGD patients seen at federally qualified community health centers in Boston and New York City from 2016 to 2019.
The researchers found that 18.9 percent of patients were nonbinary. At baseline, 84.5 percent of the individuals were prescribed GAHT and 15.3 percent reported moderate-to-severe depressive symptoms. There was a statistically lower risk for moderate-to-severe depressive symptoms over follow-up for patients prescribed GAHT versus those not prescribed GAHT (adjusted risk ratio, 0.85).
"The findings of this study suggest that integrated GAHT with primary care and low-barrier GAHT access is associated with lower rates of mental health morbidity in TGD patients," the authors write.
Two authors disclosed ties to McGraw Hill.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
Dietary Patterns May Be Associated With Depressive Symptoms
WEDNESDAY, June 4, 2025 -- Dietary patterns seem to be associated with depressive symptoms, according to a study published online June 3 in BMJ Nutrition, Prevention &...
Quality Improvement Strategy Improves Depression, Anxiety Screening With Epilepsy
WEDNESDAY, June 4, 2025 -- A quality improvement strategy can improve electronic health record-based screening for depression and anxiety in people with epilepsy, according to a...
Depression Across the Life Course Linked to Increased Risk for Dementia
TUESDAY, June 3, 2025 -- Depression across the life course is associated with an increased risk for dementia, according to a study published online May 29 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.